MedTrace Logo

Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke

NCT07590076 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 840

Last updated 2026-05-18

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:

1. After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors?
2. Does the effects of the volunteer support last over 3 to 6 months after being discharged home?

Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.

Participants will:

* Either receive volunteer support over an 8-week time period OR receive no additional volunteer support
* Continue with their usual care plan and receive educational resources from the research team during the study
* Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge

Conditions

  • Stroke
  • Stroke Rehabilitation
  • Transitional Care

Interventions

BEHAVIORAL

Discharge Assistance and Supports at Home (DASH)

One-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types: i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services).

Sponsors & Collaborators

  • March of Dimes, Canada

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Bruyère Health Research Institute.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2028-01-31
Completion
2028-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07590076 on ClinicalTrials.gov